ThaMa-Vet has launched the latest addition to its Pox Syringes family, the ThaMa 551 Vaccinator, which is designed to revolutionize the fowl pox vaccination process. This ultra-precise syringe delivers unparalleled efficiency and ease of use.
The ThaMa 551 is a groundbreaking fowl pox vaccinator with a 5.0cc capacity, capable of administering over 2,000 shots per vial. Engineered for simplicity and reliability, it introduces a level of precision that transforms poultry vaccination into a streamlined process. This newly developed vaccinator represents a significant upgrade over traditional methods, offering enhanced safety and cost savings.
Key Features and Benefits:
- Revolutionary Precision: The «eye-of-the-needle» delivery ensures accurate dosing, reducing disease rates.
- Simplified Operation: With its automatic one-needle design, the ThaMa 551 enables a single worker to complete the fowl pox vaccination process with ease and efficiency.
- Enhanced Safety: The syringe virtually eliminates the risk of painful hand injuries, ensuring a safer working environment.
- Cost-Effective Design: By minimizing vaccine waste and lowering labor requirements, the ThaMa 551 delivers significant cost savings for poultry operations.
- Unmatched Comfort: Designed for prolonged use, the ThaMa 551 offers maximum comfort, making long vaccination sessions less strenuous.
The ThaMa 551 not only simplifies the vaccination process but also ensures the well-being of both workers and poultry. Its innovative design guarantees clean, safe, and effective administration, making it an essential tool for poultry farms aiming to optimize their operations.
The new vaccinator alongside ThaMa-Vet’s popular 552 – two needles pox vaccinator and 551 2cc pox vaccinator will be presented by the company at Booth B19008 at IPPE 2025 which will take place on January 28–30, 2025 in Atlanta, Georgia, USA.
